Latest news
Novo Nordisk Earnings: Price Pressure Growing with Oral Cash Pay Success and Another Cagrisema Miss - MorningstarMorningstar · Thu, 06 Aug 2026 14:35:33 GMTEli Lilly Earnings: Strong Q2 and Higher Margin Expectations - MorningstarMorningstar · Thu, 06 Aug 2026 14:31:33 GMTNovo Nordisk's Pipeline Paradox: Better Numbers, Bleaker Narrative - AD HOC NEWSAD HOC NEWS · Wed, 05 Aug 2026 19:40:50 GMTNovo CEO faces investor grilling after outlook hike soured by pipeline concerns - BNN BloombergBNN Bloomberg · Wed, 05 Aug 2026 19:22:43 GMTNovo CEO looks to speed up R&D as share drop shows gap with Lilly - ReutersReuters · Wed, 05 Aug 2026 15:33:40 GMTNovo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 12:00:00 GMTNovo's upbeat forecast can't overcome disappointments from oral Wegovy, CagriSema - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 08:06:57 GMTNovo outlook hike falls flat as Wegovy pill sales fail to impress - ReutersReuters · Tue, 04 Aug 2026 21:15:59 GMT